— Know what they know.
Not Investment Advice
Also trades as: M7T.AX (ASX) · $vol 0M

TDMMF OTC

Mach7 Technologies Limited
1W: +10.5% 1M: -19.8% 3M: -24.7% YTD: -64.3% 1Y: -67.9% 3Y: -55.4% 5Y: -79.4%
$0.16
+0.02 (+10.46%)
 
Weekly Expected Move ±23.0%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Strong Sell · Power 35 · $37.7M mcap · 200M float · 0.0002% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$37.7M
52W Range0.1453-0.50035
Volume5,000
Avg Volume329
Beta0.97
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTeri Thomas
Employees296
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2015-12-31
Websitemach7t.com
120 Kimball Avenue
South Burlington, VT 05403
US
802 861 7745
About Mach7 Technologies Limited

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists' workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms